Weight Loss, obesity drugs
Ozempic and similar GLP-1 weight-loss medications are designed to be a lifelong treatment. But a new study finds the majority ...
The average weight loss among those taking the new drug was 15.7% after 68 weeks, compared to 3.1% for those taking a placebo. Shares sank to their lowest point in over a year after the ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...
The move comes just over a week after rival Eli Lilly cut the price for vials of its weight-loss ... copies of Wegovy while the medicines were in shortage are also running out of time to ...
Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.
The FBI is warning about counterfeit weight loss drugs being sold that claim to have semaglutide, the key ingredient in ...
The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results